Laura Ory

Laura joined Health Advances in 2025 and has in-depth experience in opportunity assessment and commercialization strategy for routine and specialty tests across the US, Europe, and emerging markets. Laura's expertise spans infectious disease, oncology, women’s health, and rare diseases, as well as the unique considerations for launching tests in tandem with therapeutics.

Laura earned an MBA from Stanford Graduate School of Business, where she was an Arjay Miller Scholar. She also holds a BA in Chemistry & Physics, magna cum laude, from Harvard University.